3Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol, 1993, 46: 1323-1330.
4Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol, 1990, 11: 272-276.
5Fontana RJ, Seeff LB, Andrade RJ, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology, 2010, 52: 730-742.
6Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol, 1995, 22: 696-699.
7Kleiner DE. The pathology of drug-induced liver injury. Semin Liver Dis, 2009, 29: 364-372.
8Li MK, Crawford JM. The pathology of cholestasis. Semin Liver Dis, 2004, 24: 21-42.
9Velayudham LS, Farrell GC. Drug induced cholestasis. Expert Opin Drug Saf, 2003, 2: 287-304.
10Suzuki A, Brunt EM, Kleiner DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology, 2011, 54:931-939.
